Wotnews is an Australian news monitoring service. Register FREE to monitor Biotechnology Industry and Peplin.
Biotechnology Industry and Peplin
Highlights this month
-
Completed its US$6.7 million purchase of private ..
Peplin completes Neosil buy
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world. Peplin has completed its US$6.7 million purchase of private ...
Life Scientist - 1 month, 1 week ago
-
Begun phase three clinical trials of its skin cancer gel ...
Trial for sun spot gel
BIOTECH company Peplin has begun phase three clinical trials of its skin cancer gel for the treatment of sun spots and pre-cancerous lesions.
The Australian Business News - 2 months, 3 weeks ago
-
Launched the next phase in its clinical trials of a ...
Peplin salve a step closer
PHARMACEUTICAL company Peplin has launched the next phase in its clinical trials of a weed - derived gel for the treatment of pre - cancerous skin lesions.The trial will use ...
The Age - 5 months, 1 week ago
-
Returning to its shareholders for a third time to get ...
Peplin fretting for float
Australian skin cancer researcher Peplin is returning to its shareholders for a third time to get approval to launch on the Nasdaq, but this time it is a step closer, ...
The Age - 8 months, 1 week ago
-
Renewed investor approval for a US float after holding off ...
Peplin revives float bid
AUSTRALIAN skin cancer researcher Peplin has renewed investor approval for a US float after holding off a Nasdaq listing for the past three months.
Herald Sun - 10 months, 2 weeks ago
-
Shifting its parent company to the US, contrasting with statements ...
Biotech vows 'to stay local'
Biotechnology group Peplin is shifting its parent company to the US, contrasting with statements a year ago to remain an Australian company.
Courier Mail Business News - 1 year, 3 months ago
1 month, 1 week ago
Peplin completes Neosil buy
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world. Peplin has completed its US$6.7 million purchase of private ...
Life Scientist - 10:35 a.m. Thursday 23rd October 2008
Life Scientist - 10:35 a.m. Thursday 23rd October 2008
2 months, 3 weeks ago
Trial for sun spot gel
BIOTECH company Peplin has begun phase three clinical trials of its skin cancer gel for the treatment of sun spots and pre-cancerous lesions.
The Australian Business News - midnight Wednesday 10th September 2008
The Australian Business News - midnight Wednesday 10th September 2008
2 months, 3 weeks ago
Cutler Innovation Review; Starpharma Up 60% On Durex Deal; Peplin Begins Phase III Trial
The 206-page Review of the National innovation System by Dr Terry Cutler says more about government procedures than biotechnology; Starpharma signs $100 million Durex licence to coat condoms with its ...
Biotech Daily - 5:25 p.m. Tuesday 9th September 2008
Biotech Daily - 5:25 p.m. Tuesday 9th September 2008
Peplin into Phase III
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world. Peplin [ASX: PLI] has begun a Phase III trial of its ...
Life Scientist - 2:43 p.m. Tuesday 9th September 2008
Life Scientist - 2:43 p.m. Tuesday 9th September 2008
3 months ago
Emeryville biotech Peplin scores $24M in funding
An Emeryville company attempting to tap an Australian weed for a treatment of a precancerous skin condition has landed a new top management team and a $24 million investment after ...
bizjournals - 10:44 a.m. Sunday 31st August 2008
bizjournals - 10:44 a.m. Sunday 31st August 2008
Emeryville biotech Peplin scores $24M in funding
An Emeryville company attempting to tap an Australian weed for a treatment of a precancerous skin condition has landed a new top management team and a $24 million investment after ...
bizjournals - 10:44 a.m. Sunday 31st August 2008
bizjournals - 10:44 a.m. Sunday 31st August 2008
3 months, 1 week ago
Aldridge quits Peplin
A daily e - mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.US - incorporated biotech Peplin ( ASX : PLI ) ...
Life Scientist - 5:17 p.m. Thursday 21st August 2008
Life Scientist - 5:17 p.m. Thursday 21st August 2008
Aldridge quits Peplin
A daily e - mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.US - incorporated biotech Peplin ( ASX : PLI ) ...
Life Scientist - 5:17 p.m. Thursday 21st August 2008
Life Scientist - 5:17 p.m. Thursday 21st August 2008
5 months, 3 weeks ago
Peplin Withdraws US IPO
An Australian company called Peplin Inc ., which originally filed to come public in August 2007, has filed with the SEC to withdraw its IPO paperwork.The emerging biotech was going ...
24/7 Wall St - 8:35 a.m. Tuesday 10th June 2008
24/7 Wall St - 8:35 a.m. Tuesday 10th June 2008
1 year, 2 months ago
Peplin US plan gets support
AUSTRALIAN skin cancer researcher Peplin, which is shifting its main stock market listing to the United States, says the appetite for American biotechnology floats is unclear following the sub-prime crisis.
Herald Sun - 1 a.m. Tuesday 2nd October 2007
Herald Sun - 1 a.m. Tuesday 2nd October 2007
1 year, 3 months ago
Biotech vows 'to stay local'
Biotechnology group Peplin is shifting its parent company to the US, contrasting with statements a year ago to remain an Australian company.
Courier Mail Business News - 12:36 a.m. Monday 13th August 2007
Courier Mail Business News - 12:36 a.m. Monday 13th August 2007
1 year, 4 months ago
Analysts impressed by gel
ANALYSTS yesterday gave the thumbs up to a skin cancer trial of a gel developed by Brisbane biotech company Peplin.
Courier Mail Business News - 12:35 a.m. Friday 20th July 2007
Courier Mail Business News - 12:35 a.m. Friday 20th July 2007
1
